|
000
| 01429cam 2200289za 4500 |
|---|
| 001 | 9.848104 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20221107153608 |
|---|
| 007 | cr ||||||||||| |
|---|
| 008 | 171130s2018 onca o f000 0 eng d |
|---|
| 020 | |a9780660240725|z9780660240732 |
|---|
| 040 | |aCaOODSP|beng |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aNR16-186/2017E-PDF |
|---|
| 110 | 2 |aNational Research Council Canada. |
|---|
| 245 | 10|aFunctional characterization |h[electronic resource]. |
|---|
| 260 | |a[Ottawa] : |bNational Research Council Canada, |c2018. |
|---|
| 300 | |a[4] p. : |bcol. ill. |
|---|
| 500 | |aIssued also in French under title: Caractérisation fonctionnelle. |
|---|
| 500 | |aCaption title. |
|---|
| 500 | |a"January 2018." |
|---|
| 520 | |a"Biologics and vaccine developers leverage our functional characterization expertise to translate the development of promising treatments in the lab to clinical trials. We also transfer our data and methods to Contract Research Organizations (CROs) and Contract Manufacturing Organizations (CMOs), enabling them to offer new services while strengthening the Canadian biopharma ecosystem"--P. [1]. |
|---|
| 530 | |aIssued also in print format. |
|---|
| 693 | 4|aPharmaceutical biotechnology |
|---|
| 775 | 08|tCaractérisation fonctionnelle |w(CaOODSP)9.848106 |
|---|
| 776 | 0#|tFunctional characterization |w(CaOODSP)9.848105 |
|---|
| 856 | 40|qPDF|s200 KB|uhttps://publications.gc.ca/collections/collection_2018/cnrc-nrc/NR16-186-2017-eng.pdf |
|---|